All patients with myeloma should be treated for bone disease.
Although there are effective agents to treat bone disease in patients with myeloma, many patients are not receiving them, explained G. David Roodman, MD, PhD, the Kenneth Wiseman Professor of Medicine at Indiana University School of Medicine.
Almost all guidelines now recommend that patients with myeloma are treated for bone disease, regardless of whether or not legions appear on X-rays, because these therapies can improve quality of life and extend survival, Roodman said.
Shared Model of Care Post-HCT Offers Safe Follow-Up, Reduces Patient Burden
Published: March 19th 2025 | Updated: March 19th 2025Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care.